Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 4, 2013, Pages 350-357

  Oelrich, B ^a   Dewell, A ^a   Gardner, C D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fish oil; LDL; LDL particle size; LDL phenotype; LDL subclass; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CALIFORNIA; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84875073796     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.06.003     Document Type: Article

References (42)

1. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287(3):356-359. jbr10281 [pii].
2. Ford E.S., Li C., Zhao G., Pearson W.S., Mokdad A.H. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med 2009, 169(6):572-578. 169/6/572 [pii] 10.1001/archinternmed.2008.599.
3. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2(8666):757-761. S0140-6736(89)90828-3 [pii].
4. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet 1999, 354(9177):447-455. S0140673699070725 [pii].
5. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
6. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(5 Suppl):1645S-1654S.
7. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000, 35(2):265-270. S0735-1097(99)00548-3 [pii].
8. Will the rising tide of Rx Omega-3s float the fish oil supplement market? FDC reports. The Tan Sheet 2011, 19(4):5. FDC-Reports.
9. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996, 276(11):875-881.
10. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276(11):882-888.
11. Galeano N.F., Al-Haideri M., Keyserman F., Rumsey S.C., Deckelbaum R.J. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res 1998, 39(6):1263-1273.
12. Nigon F., Lesnik P., Rouis M., Chapman M.J. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991, 32(11):1741-1753.
13. de Graaf J., Hak-Lemmers H.L., Hectors M.P., Demacker P.N., Hendriks J.C., Stalenhoef A.F. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991, 11(2):298-306.
14. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., Beilin L.J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000, 102(11):1264-1269.
15. Krauss R.M., Dreon D.M. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995, 62(2):478S-487S.
16. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006, 84(6):1290-1298. 84/6/1290 [pii].
17. Kelley D.S., Siegel D., Vemuri M., Mackey B.E. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007, 86(2):324-333. 86/2/324 [pii].
18. Stalenhoef A.F., de Graaf J., Wittekoek M.E., Bredie S.J., Demacker P.N., Kastelein J.J. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 2000, 153(1):129-138. S0021915000003816 [pii].
19. Tinker L.F., Parks E.J., Behr S.R., Schneeman B.O., Davis P.A. (n-3) fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. J Nutr 1999, 129(6):1126-1134.
20. Suzukawa M., Abbey M., Howe P.R., Nestel P.J. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 1995, 36(3):473-484.
21. Contacos C., Barter P.J., Sullivan D.R. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb 1993, 13(12):1755-1762.
22. Rivellese A.A., Maffettone A., Vessby B., Uusitupa M., Hermansen K., Berglund L., et al. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis 2003, 167(1):149-158. S0021915002004240 [pii].
23. Isherwood C., Wong M., Jones W.S., Davies I.G., Griffin B.A. Lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell Mol Biol (Noisy-le-grand) 2010, 56(1):52-58.
24. Khandelwal S., Demonty I., Jeemon P., Lakshmy R., Mukherjee R., Gupta R., et al. Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults. Br J Nutr 2009, 102(5):722-732. S0007114509297170 [pii] 10.1017/S0007114509297170.
25. Mostad I.L., Bjerve K.S., Lydersen S., Grill V. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Eur J Clin Nutr 2008, 62(3):419-429. 1602703 [pii] 10.1038/sj.ejcn.1602703.
26. Ambring A., Friberg P., Axelsen M., Laffrenzen M., Taskinen M.R., Basu S., et al. Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci (Lond) 2004, 106(5):519-525. [pii]. 10.1042/CS20030315 CS20030315.
27. Brude I.R., Drevon C.A., Hjermann I., Seljeflot I., Lund-Katz S., Saarem K., et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 1997, 17(11):2576-2588.
28. Patti L., Maffettone A., Iovine C., Marino L.D., Annuzzi G., Riccardi G., et al. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia. Atherosclerosis 1999, 146(2):361-367. S0021915099001495 [pii].
29. Mostad I.L., Bjerve K.S., Bjorgaas M.R., Lydersen S., Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006, 84(3):540-550. 84/3/540 [pii].
30. Homma Y., Ohshima K., Yamaguchi H., Nakamura H., Araki G., Goto Y. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin:cholesterol acyltransferase and lipid transfer protein. Atherosclerosis 1991, 91(1-2):145-153.
31. Blair S.N., Haskell W.L., Ho P., Paffenbarger R.S., Vranizan K.M., Farquhar J.W., et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985, 122(5):794-804.
32. Kulkarni K.R. Cholesterol profile measurement by vertical auto profile method. Clin Lab Med 2006, 26(4):787-802. S0272-2712(06)00074-6 [pii] 10.1016/j.cll.2006.07.004.
33. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990, 82(2):495-506.
34. Harris W.S., Sands S.A., Windsor S.L., Ali H.A., Stevens T.L., Magalski A., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110(12):1645-1649. [pii]. 10.1161/01.CIR.0000142292.10048.B2 01.CIR.0000142292.10048.B2.
35. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189(1):19-30. S0021-9150(06)00069-4 [pii] 10.1016/j.atherosclerosis.2006.02.012.
36. Minihane A.M., Khan S., Leigh-Firbank E.C., Talmud P., Wright J.W., Murphy M.C., et al. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000, 20(8):1990-1997.
37. Calabresi L., Donati D., Pazzucconi F., Sirtori C.R., Franceschini G. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis 2000, 148(2):387-396. S0021915099002671 [pii].
38. Hartweg J., Farmer A.J., Holman R.R., Neil A. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 2009, 20(1):30-38.
39. Mittendorfer B., Sidossis L.S. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am J Clin Nutr 2001, 73(5):892-899.
40. Nestel P.J., Connor W.E., Reardon M.F., Connor S., Wong S., Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984, 74(1):82-89. 10.1172/JCI111422.
41. Watson T.D., Caslake M.J., Freeman D.J., Griffin B.A., Hinnie J., Packard C.J., et al. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb 1994, 14(6):902-910.
42. Selby J.V., Austin M.A., Newman B., Zhang D., Quesenberry C.P., Mayer E.J., et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993, 88(2):381-387.